Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liang Guan

Showing results (251-260 of 367) with videos related to

Pageof 37
Sort By:
Molecular Cell|October 9, 2018
Regulation of the Hippo Pathway by Phosphatidic Acid-Mediated Lipid-Protein InteractionHan Han, Ruxi Qi, Jeff Jiajing Zhou, et al.
The Journal of Biological Chemistry|December 24, 2013
Glyceraldehyde-3-phosphate dehydrogenase is activated by lysine 254 acetylation in response to glucose signalTingting Li, Mengxi Liu, Xu Feng, et al.
American Journal of Physiology. Cell Physiology|July 25, 2008
A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expressionCarolyn L Buller, Robert D Loberg, Ming-Hui Fan, et al.
Nature Communications|July 2, 2014
Rag GTPases are cardioprotective by regulating lysosomal functionYoung Chul Kim, Hyun Woo Park, Sebastiano Sciarretta, et al.
Nature Communications|January 13, 2021
Structural insights into TSC complex assembly and GAP activity on RhebHuirong Yang, Zishuo Yu, Xizi Chen, et al.
Cell Reports|October 26, 2018
Oncogenic R132 IDH1 Mutations Limit NADPH for De Novo Lipogenesis through (D)2-Hydroxyglutarate Production in Fibrosarcoma SellsMehmet G Badur, Thangaselvam Muthusamy, Seth J Parker, et al.
Science (New York, N.Y.)|January 9, 2015
Metabolism. Differential regulation of mTORC1 by leucine and glutamineJenna L Jewell, Young Chul Kim, Ryan C Russell, et al.
Oncogene|November 8, 2022
TET2 deficiency sensitizes tumor cells to statins by reducing HMGCS1 expressionSi-Jia Sun, Ying-Jie Ai, Kun-Long Duan, et al.
Nature Cell Biology|May 21, 2013
ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinaseRyan C Russell, Ye Tian, Haixin Yuan, et al.
Oncotarget|April 1, 2015
D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growthShenghong Ma, Bowen Jiang, Wanglong Deng, et al.
Pageof 37

Showing results (251-260 of 367) with videos related to

Sort By:
Pageof 37
Molecular Cell|October 9, 2018
Regulation of the Hippo Pathway by Phosphatidic Acid-Mediated Lipid-Protein InteractionHan Han, Ruxi Qi, Jeff Jiajing Zhou, et al.
The Journal of Biological Chemistry|December 24, 2013
Glyceraldehyde-3-phosphate dehydrogenase is activated by lysine 254 acetylation in response to glucose signalTingting Li, Mengxi Liu, Xu Feng, et al.
American Journal of Physiology. Cell Physiology|July 25, 2008
A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expressionCarolyn L Buller, Robert D Loberg, Ming-Hui Fan, et al.
Nature Communications|July 2, 2014
Rag GTPases are cardioprotective by regulating lysosomal functionYoung Chul Kim, Hyun Woo Park, Sebastiano Sciarretta, et al.
Nature Communications|January 13, 2021
Structural insights into TSC complex assembly and GAP activity on RhebHuirong Yang, Zishuo Yu, Xizi Chen, et al.
Cell Reports|October 26, 2018
Oncogenic R132 IDH1 Mutations Limit NADPH for De Novo Lipogenesis through (D)2-Hydroxyglutarate Production in Fibrosarcoma SellsMehmet G Badur, Thangaselvam Muthusamy, Seth J Parker, et al.
Science (New York, N.Y.)|January 9, 2015
Metabolism. Differential regulation of mTORC1 by leucine and glutamineJenna L Jewell, Young Chul Kim, Ryan C Russell, et al.
Oncogene|November 8, 2022
TET2 deficiency sensitizes tumor cells to statins by reducing HMGCS1 expressionSi-Jia Sun, Ying-Jie Ai, Kun-Long Duan, et al.
Nature Cell Biology|May 21, 2013
ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinaseRyan C Russell, Ye Tian, Haixin Yuan, et al.
Oncotarget|April 1, 2015
D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growthShenghong Ma, Bowen Jiang, Wanglong Deng, et al.
Pageof 37